Compensated liver disease Completed Phase 3 Trials for Glecaprevir (DB13879)

Also known as: Compensated Cirrhosis / Liver Cirrhosis / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0020249 (Compensated liver disease)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02642432A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated CirrhosisTreatment